GS-US-292-0104 A Phase 3, Double blind study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Verus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Di12/01/2012 - 07/31/2015 (PI)
Gilead Sciences, Inc.
GS-US-292-0111 A Phase 3, Double blind study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Verus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Di12/01/2012 - 07/31/2015 (PI)
Gilead Sciences, Inc.
A Multicenter, Randomized, Open, Comparative Trial of Maraviroc Versus Etravirine each in Combination with Darrunavir/Ritonavir and Raltegravir for the Treatment of Antiretroviral-Experienced HIV02/01/2009 - 01/31/2015 (PI)
Pfizer, Inc.
GS-US-366-1216: A Phase 3b, Randomized, Double-Blind Switch Study to Evaluate the Safety and Effi…06/02/2015 - 05/31/2017 (PI)
Gilead Sciences